Viewing Study NCT06258668


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2025-12-30 @ 5:28 AM
Study NCT ID: NCT06258668
Status: RECRUITING
Last Update Posted: 2024-11-06
First Post: 2024-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module